Abstract: The invention relates to fluorinated compounds and their use as anti-epileptic, muscle-relaxing, fever-reducing and peripherally analgesically acting medications and as imaging agents. Novel fluorinated 2-amino-4-(benzylamino)phenyl carbamate derivatives of ezogabine and pharmaceutically acceptable salts or solvates thereof and their use are described.
Type:
Grant
Filed:
March 13, 2013
Date of Patent:
December 23, 2014
Assignee:
SciFluor Life Sciences, LLC
Inventors:
Mark E. Duggan, Takeru Furuya, D. Scott Edwards, Ajay Purohit
Abstract: The invention relates to fluorinated compounds and their use as integrin receptor antagonists. Novel fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives and pharmaceutically acceptable salts or solvates thereof and their use are described.
Type:
Grant
Filed:
February 7, 2014
Date of Patent:
December 2, 2014
Assignee:
SciFluor Life Sciences, LLC
Inventors:
Ben C. Askew, Richard W. Heidebrecht, Takeru Furuya, Mark E. Duggan
Abstract: The invention relates to fluorinated compounds and their use as integrin receptor antagonists. Novel fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives and pharmaceutically acceptable salts or solvates thereof and their use are described.
Type:
Application
Filed:
February 7, 2014
Publication date:
August 7, 2014
Applicant:
SCIFLUOR LIFE SCIENCES, LLC
Inventors:
Ben C. Askew, Richard W. Heidebrecht, Takeru Furuya, Mark E. Duggan
Abstract: The invention relates to fluorinated compounds and their use as anti-epileptic, muscle-relaxing, fever-reducing and peripherally analgesically acting medications and as imaging agents. Novel fluorinated 2-amino-4-(benzylamino)phenyl carbamate derivatives of ezogabine and pharmaceutically acceptable salts or solvates thereof and their use are described.
Type:
Application
Filed:
March 13, 2013
Publication date:
October 31, 2013
Applicant:
SCIFLUOR LIFE SCIENCES, LLC
Inventors:
Mark E. Duggan, Takeru Furuya, D. Scott Edwards, Ajay Purohit